Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer (Q56815464)

From Wikidata
Jump to navigation Jump to search
article by Paal F. Brunsvig et al published 21 February 2006 in Cancer Immunology, Immunotherapy
edit
Language Label Description Also known as
English
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
article by Paal F. Brunsvig et al published 21 February 2006 in Cancer Immunology, Immunotherapy

    Statements

    Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer (English)
    0 references
    0 references
    0 references
    Paal F. Brunsvig
    0 references
    Steinar Aamdal
    0 references
    Marianne K. Gjertsen
    0 references
    Carrie J. Markowski-Grimsrud
    0 references
    Ingunn Sve
    0 references
    Marianne Dyrhaug
    0 references
    Sissel Trachsel
    0 references
    Mona Møller
    0 references
    Jon A. Eriksen
    0 references
    21 February 2006
    0 references
    55
    0 references
    1553-1564
    0 references
    12
    0 references

    Identifiers

    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit